Details of the Drug Reposition

General Information of This Drug (ID: DMQ3BXV)

• Drug Name: IDDBCP-150101 (DMQ3BXV)

Information on Drug Reposition of This Drug

2 Preclinical Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Obesity	DIS47Y1K	5B81	Preclinical	[1]
Sexual dysfunction	DIS7WG2P	HA00-HA01	Preclinical	[1]

References

• [1] Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.